Present and future possibilities for early diagnosis of hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Present and future possibilities for early diagnosis of hepatocellular carcinoma

Present and future possibilities for early diagnosis of hepatocellular carcinoma

http://www.wikidata.org/entity/Q33612167

about

Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma.Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry.Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma.Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique.Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease Impact of PIVKA-II in diagnosis of hepatocellular carcinoma Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.Disturbances in the glutathione/ophthalmate redox buffer system in the woodchuck model of hepatitis virus-induced hepatocellular carcinoma.Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway.Effects of Oxymatrine on the Proliferation and Apoptosis of Human Hepatoma Carcinoma Cells.An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma.An electrochemical method to detect gamma glutamyl transpeptidase Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation.Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure.Comparative histomorphological review of rat and human hepatocellular proliferative lesions.Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients.Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma Solanine-induced reactive oxygen species inhibit the growth of human hepatocellular carcinoma HepG2 cells.Haptoglobin is a serological biomarker for adenocarcinoma lung cancer by using the ProteomeLab PF2D combined with mass spectrometry Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma.Identification of osteopontin as a novel marker for early hepatocellular carcinoma.Hepatocellular carcinoma: diagnostics and screening.Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma?Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks.Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.Tumour-associated antigens and their anti-cancer applications.Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma.

P2860

Q26781469-B31A3CC4-8F68-40B9-8176-465DFCC09340 Q26799928-5B7CEBF1-C799-47E6-AFFC-0AC224E7EA58 Q30436747-2B8032C6-79A9-4FED-BACA-F3DA07289F71 Q30635373-85272967-18E5-4D09-A873-99F5439904C7 Q31117540-1852C9E1-A956-4068-BDF3-05765A64F971 Q33626833-E32C6DB3-FA63-4455-AAF0-96F3F1B348BA Q33684858-09783038-8CE0-4405-A59A-466C94EE0FEC Q34024893-97F98609-448E-403B-846C-15092270DF2E Q34075313-DF7B3963-FF1F-4757-A7AF-E955B3378991 Q34084970-02DB70EC-5899-4E37-AEBE-5723B549B10F Q34134948-C46AB0E8-DA34-4788-95DD-815F27FDA121 Q34247089-9A3A20D3-63EA-43E9-8A52-98210268BF67 Q34464343-1903B43F-1612-4DB5-BCF1-29CD4334FF7B Q34961730-DF434B17-51C9-4D8F-8219-A6FEAF56ED76 Q35062428-E6BF575F-E6F1-4282-A891-4D458887CD60 Q35220249-83ACECC4-D4DA-4A25-B421-252D3BFEA1E3 Q35232196-1D821AAB-8E16-4303-889A-AAF236EDA411 Q35640931-895E9CE5-4259-48E9-A6C5-0E7C2A69F8AD Q35800748-9420EE1A-F734-4900-A8E0-921A4E90544D Q35865958-F2966764-4F68-4FF2-905A-90E5EAF68425 Q35963772-94C13E66-B33C-4708-A9DC-6A2519DCBC37 Q36046973-B7C6393D-53F8-48E7-A1C1-DF84BD1A8308 Q36210352-E7982E65-3B80-4912-9935-FE952176BB89 Q36293011-FF958E88-D8DB-4782-8949-D0DBA03ADCE4 Q36378791-E6FC1D03-5239-42DA-B747-75B1C599E509 Q36495366-627C3C56-E77D-486E-9FC8-5F2DBA370E45 Q36511828-DF99ECF2-7FB1-4120-8D47-749785099FDC Q36640158-49AB3E53-0D96-4670-A1AB-E0BD57B069F1 Q37215561-7AB873DF-8091-4B26-A430-A70FE536EE60 Q37218954-FED5C23F-C1AB-41CD-93EC-324CAAA030E8 Q37557988-68F9F424-7BD6-411F-B501-B571620E1AC0 Q37813192-2DBD5CEC-D7A1-4737-BCCD-BCE31FCCF192 Q38176302-9DA3CF67-74B0-4BC4-9765-F89D6E61280A Q38252622-4E47965D-38BC-4AC4-9570-77021DD9604C Q38272126-428E51FB-2F47-4E90-A197-1ABEC331E634 Q38436698-56F95463-1811-401D-AE14-FC054927D93F Q38647536-610D7C9C-C6FE-4D86-9258-931C575EE3D9 Q38725552-8858DFBC-C6BC-4510-A1D0-DC00926573D9 Q38878644-6B463356-2459-42A6-8045-159ABC037BEA Q38983451-7461C5F6-F011-4502-94EA-1277FA1AADB8

P2860

Present and future possibilities for early diagnosis of hepatocellular carcinoma

http://www.wikidata.org/entity/Q33612167

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Present and future possibilities for early diagnosis of hepatocellular carcinoma

@ast

Present and future possibilities for early diagnosis of hepatocellular carcinoma

@en

type

label

Present and future possibilities for early diagnosis of hepatocellular carcinoma

@ast

Present and future possibilities for early diagnosis of hepatocellular carcinoma

@en

prefLabel

Present and future possibilities for early diagnosis of hepatocellular carcinoma

@ast

Present and future possibilities for early diagnosis of hepatocellular carcinoma

@en

P1433

Q33612167-3D5AF7AF-4A62-473E-96E9-E9229B70F0EB

P1476

Q33612167-224A50FC-BC3E-4932-A462-F8B8AA8DCDF7

P2093

Q33612167-5C2111FA-08AC-42BC-9A3F-5BB79D8F10A6

Q33612167-AF2B0A7D-9DB3-4346-B485-4C1009BCCA09

P2860

Q33612167-00EDF6B8-B069-4CA7-A11E-A42717BF8256

Q33612167-0EABB373-4245-4EFB-83C4-F5C3706EAA16

Q33612167-16BFC60E-9106-4E4F-BA7D-2BCF3D2C05BB

Q33612167-1812F760-EFAE-4DC9-B147-11C35EF12116

Q33612167-1F28F8D8-6B1B-4C96-AD69-C1D27B7F1DFF

Q33612167-2023569A-3977-46C3-9600-245B7135135E

Q33612167-22913EEA-85B8-4FBC-9E18-59A94409D28B

Q33612167-22D61C55-49FC-4717-9CAE-A7AC263948D0

Q33612167-27017598-64CD-4E3F-BC17-173F5D12D726

Q33612167-3F74AE8F-9BCD-4850-9F23-A664CC29CDE6

P304

Q33612167-1580AD83-5F2E-496A-AC8C-020E6B34D7B7

P31

Q33612167-07674769-6067-4EC9-926F-F4E7E3E99901

P356

Q33612167-A66ABF66-C191-40E3-A203-7534EC677A64

P407

Q33612167-0A88676E-449B-40D5-94E2-37CFC948C537

P433

Q33612167-DA8D7199-B0E8-406F-A294-C35CFC2BB7FC

P478

Q33612167-25AC256C-AA78-4377-BF32-B10AE8F62D60

P50

Q33612167-C2ACC706-D3C3-4F49-AD4C-740721DCB4C3

P577

Q33612167-1E442CCA-08F5-4379-BD1C-F120BDE348E7

P698

Q33612167-E2ED5EDC-CDE0-4155-BC2A-B15A801E5B3A

P932

Q33612167-17C761E4-F737-453F-90BA-AA23B9663532

P356

P1433

World Journal of Gastroenterology

P1476

Present and future possibilities for early diagnosis of hepatocellular carcinoma

@en

P2093

Janusz Cianciara

http://www.w3.org/2001/XMLSchema#string

Piotr Stefaniuk

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

Global cancer statistics, 2002

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

Hepatocellular carcinoma

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

P304

418-424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V16.I4.418

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Alicja Wiercińska-Drapało

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20101765

http://www.w3.org/2001/XMLSchema#string

P932

2811792

http://www.w3.org/2001/XMLSchema#string